Results 161 to 170 of about 3,094,176 (247)

White Coat Hypertension in Primary Care: A Narrative Review. [PDF]

Cureus
Avasia A, Medipally M, Parasnis M.
europepmc   +1 more source

Interaction between white coat effect and hypertension on arterial stiffness

OBJECTIVE: White coat effect (WCE) is a debated risk factor for cardiovascular diseases (CVD), and the current findings regarding its association with arterial stiffness in hypertension remain inconsistent.
Ma, Jing, Shen, Cuiqin, Li, Zhaojun, Jin, Lin, Wang, Ning, Wang, Xinqi, Chen, Anni, Yang, Lan, Li, Zhenyi, Li, Xinyi   +9 more
core   +1 more source

Prospective randomised double‐blind trial: holmium laser lithotripsy with vs without Moses™ 2.0

BJU International, EarlyView.
Objective To assess the effect of Moses™ 2.0 (Lumenis Be Ltd., Yokneam Illit, Israel; Boston Scientific, Marlborough, MA, USA) for lithotripsy of renal stones of 8–20 mm in diameter on operative time, surgeon workload, and retropulsion. Subjects/Patients and Methods In our multicentre, randomised, double‐blind clinical trial, patients were randomised 1:
Kimberly A. Maciolek, Naren Nimmagadda, Aaron X. Lee, Amy M. Reed, Ryan S. Hsi, Tatsuki Koyama, Connor M. Forbes, Matthew S. Lee, Cyrus Chehroudi, Ezra J. Margolin, Ben H. Chew, Seth K. Bechis, Mitchell R. Humphreys, Michael E. Lipkin, Manoj Monga, Ojas Shah, Karen L. Stern, Roger L. Sur, Sri Sivalingam, Nicole L. Miller   +19 more
wiley   +1 more source

Direct evidence implicating the asymmetrical dimethylarginine (ADMA)‐dimethylarginine dimethylaminohydrolase 1 (DDAH1) pathway in cerebrovascular dysfunction and stroke pathogenesis in mice

British Journal of Pharmacology, EarlyView.
Abstract Background and Purpose Asymmetrical dimethylarginine (ADMA) is an endogenous inhibitor of nitric oxide synthase (NOS), whereas dimethylaminohydrolase 1 (DDAH1) is primarily responsible for its metabolism. However, the roles of DDAH1 in cerebrovascular regulation are poorly understood. Furthermore, despite evidence that elevated ADMA levels are
Arun Flynn, Alexandra Riddell, Ashton Bernard, Jennifer Haggarty, Stefan Weidt, Jawza Alenazi, Erika Trabold, Delyth Graham, Laura B. Dowsett, James Leiper, Alyson A. Miller   +10 more
wiley   +1 more source

Cardiovascular Alterations and Management of Patients With White Coat Hypertension: A Meta-Analysis. [PDF]

Front Pharmacol, 2020
Xiang H, Xue Y, Wang J, Weng Y, Rong F, Peng Y, Ji K.   +6 more
europepmc   +1 more source

Kininase I drives angiotensin II‐induced hypertension through activation of the bradykinin B1 receptor

British Journal of Pharmacology, EarlyView.
Abstract Background and Purpose Kininase I, comprising carboxypeptidase N (CPN) and carboxypeptidase M, regulates kinin activity and is up‐regulated during injury, inflammation and immune activation. Under these conditions, kininase I converts bradykinin and kallidin into des‐Arg kinins, primary endogenous agonists of the bradykinin B1 receptor (R ...
Acacia White, Drew Theobald, Alexandra Johnston, David A. Tulis, Johanna Hannan, Srinivas Sriramula   +5 more
wiley   +1 more source

Association Between Metabolic and Atherogenic Indices and Circadian Blood Pressure Patterns in White-Coat Hypertension. [PDF]

Medicina (Kaunas)
Akgul A, Ikhlef C, Tunca Ç, Aylı MD.
europepmc   +1 more source

Hyperlipidaemia in youth with type 1 diabetes: Are current guidelines clinically useful?

Diabetic Medicine, EarlyView.
Abstract Aims Dyslipidaemia in youth with type 1 diabetes mellitus (T1D) is emerging as an important modifiable cardiovascular risk factor. International consensus guidelines to screen this entity have evolved over time. To further evaluate this in an Australian context, we investigated adherence to such guidelines over the course of patient care ...
Farrah Rodrigues, Mary White, Michele A. O'Connell   +2 more
wiley   +1 more source

Blood pressure determinants of target organ damage among adults with white coat hypertension with a focus on nocturnal hypertension and blood pressure dipping. [PDF]

J Hum Hypertens
Papasotiriou I, Spiliopoulou S, Barlas G, Dragonas D, Rizogiannis K, Manios E.   +5 more
europepmc   +1 more source

Conventional adherence assessment methods are low‐sensitivity diagnostic tests in people with type 2 diabetes: The TARGET study

Diabetic Medicine, EarlyView.
Abstract Aims To evaluate the performance of conventional adherence assessment methods against objective chemical adherence testing (CAT) in people with type 2 diabetes. Methods In this prospective cohort study, 90 participants with type 2 diabetes attending primary care were assessed using CAT (n = 49), medication possession ratio (MPR; n = 60) and ...
Hanad Osman, Sian Jenkins, Prashanth Patel, Kamlesh Khunti, Samuel Seidu, Pankaj Gupta   +5 more
wiley   +1 more source